2019-11-03 12:30:00 Sun ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
Chinese trade delegation offers to boost purchases of U.S. agricultural products to reach an interim trade deal with the Trump administration. Chinese Vice Premier Liu He indicates an active key interest from China in buying $40 billion to $50 billion American agricultural products such as soybeans and pork bellies. China expects the Trump team to institute another tariff reprieve in light of the interim partial trade agreement. Thus, there would be no 5% tariff hike on top of the current 25% tariffs on $250 billion Chinese goods. China further expects the Trump administration to circumvent blacklisting some Chinese tech titans such as HuaWei and Tencent. In response, however, U.S. trade rep Robert Lighthizer emphasizes that the HuaWei case should be kept separate from the interim partial trade deal.
Chinese trade delegation indicates a key interest in keeping the renminbi currency steady within reasonable ranges of exchange rates. Any new competitive currency manipulation or misalignment would not serve in the best interests of America and China. Moreover, China plans to further open up its asset markets by lifting foreign capital investment restrictions from April 2020 onwards.
On balance, peace and engagement can help attain the best compromise in Sino-American trade negotiations.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2024-05-05 10:31:00 Sunday ET
Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its
2023-10-14 10:32:00 Saturday ET
Jonathan Baker frames the current debate over antitrust merger review and enforcement in America. Jonathan Baker (2019) The antitrust paradi
2018-05-07 07:32:00 Monday ET
President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries such as Canada, Bri
2019-09-15 14:35:00 Sunday ET
U.S. Treasury officially designates China a key currency manipulator in the broader context of Sino-American trade dispute resolution. The U.S. Treasury cla
2019-12-19 14:43:00 Thursday ET
JPMorgan Chase CEO Jamie Dimon views wealth inequality as a major economic problem in America. Dimon now warns that the rich Americans have been getting wea
2018-01-02 12:39:00 Tuesday ET
Goldman Sachs takes a $5 billion net income hit that results from its offshore cash repatriation under the new Trump tax law. This income hit reflects 10%-1